Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2024 Earnings Call Transcript

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2024 Earnings Call Transcript February 19, 2025

Karyopharm Therapeutics Inc. beats earnings expectations. Reported EPS is $-0.24, expectations were $-0.26.

Operator: Good morning. My name is Jewel, and I will be your conference operator today. At this time, I would like to welcome everyone to Karyopharm Therapeutics Fourth Quarter and Full Year 2024 Financial Results Conference Call. There will be a question-and-answer session to follow. Please...